In addition, potassium-based replacements could affect the health of susceptible people (“with major impairment of renal function because of chronic kidney disease or other morbidity, and those taking medications such as angiotensin-converting enzyme inhibitors and potassium-sparing diuretics that reduce renal excretion of potassium”). The gene discussed is ACE; the disease is chronic kidney disease.